• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Rosecliff Acquisition Corp I (Amendment)

    2/14/23 7:42:55 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care
    Get the next $RCLF alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A Saba Capital Management, L.P.: Form SC 13G/A - Filed by newsfilecorp.com

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No.2)*

    Rosecliff Acquisition Corp I

    (Name of Issuer)

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

     

    77732R103

    (CUSIP Number)

     

    December 31, 2022

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     [_]  Rule 13d-1(b)

     [X]  Rule 13d-1(c)

     [_]  Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    SCHEDULE 13G/A

    CUSIP No.           77732R103


    1 Names of Reporting Persons

    Saba Capital Management, L.P.
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    Delaware
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
     
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    PN; IA
           

    The percentages used herein are calculated based upon 31,625,000 shares of common stock outstanding as of November 25, 2022, as disclosed in the company's 8-K filed December 22, 2022.

    Page 2 of 7


    SCHEDULE 13G/A

    CUSIP No.           77732R103


    1 Names of Reporting Persons

    Boaz R. Weinstein
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    United States
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
     
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    IN
           

    The percentages used herein are calculated based upon 31,625,000 shares of common stock outstanding as of November 25, 2022, as disclosed in the company's 8-K filed December 22, 2022.

    Page 3 of 7


    CUSIP No.           77732R103


    1 Names of Reporting Persons

    Saba Capital Management GP, LLC
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    Delaware
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
     
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    OO
           

    The percentages used herein are calculated based upon 31,625,000 shares of common stock outstanding as of November 25, 2022, as disclosed in the company's 8-K filed December 22, 2022.

    Page 4 of 7


    Item 1.

    (a) Name of Issuer: Rosecliff Acquisition Corp I

    (b) Address of Issuer's Principal Executive Offices: 767 Fifth Ave, 34th Floor, New York, NY, 10153

    Item 2.

    (a) Name of Person Filing: Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"), Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"), and Mr. Boaz R. Weinstein (together, the "Reporting Persons").  The Reporting Persons have entered into a Joint Filing Agreement, dated June 18, 2021, pursuant to which the Reporting Persons have agreed to file this statement and any subsequent amendments hereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.  Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.  The filing of this statement should not be construed as an admission that any of the forgoing persons or the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the Common Stock reported herein.

    (b) Address of Principal Business Office or, if None, Residence:  The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174.

    (c) Citizenship: Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States.

    (d) Title and Class of Securities: Common stock, $0.0001 Par Value (the "Common Stock").

    (e) CUSIP No.: 77732R103

    Item 3.  If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    (a) [_] Broker or dealer registered under Section 15 of the Act;

    (b) [_] Bank as defined in Section 3(a)(6) of the Act;

    (c) [_] Insurance company as defined in Section 3(a)(19) of the Act;

    (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940;

    (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

    (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

    (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

    (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

    (j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

    Page 5 of 7


    (k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

    Item 4. Ownership

    (a) Amount Beneficially Owned:    The information required by Items 4(a) - (c) is set forth in Rows (5) - (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

    Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]

    Item 6. Ownership of more than Five Percent on Behalf of Another Person.  N/A

    Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. N/A

    Item 8. Identification and classification of members of the group. N/A

    Item 9. Notice of Dissolution of Group.  N/A

    Item 10. Certifications.

    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    Page 6 of 7


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated:  February 14, 2023

    /s/ Signature  Michael D'Angelo

    Name: Michael D'Angelo

    Title: Chief Compliance Officer

    Boaz R. Weinstein

    By: Michael D'Angelo

    Title: Attorney-in-fact***

    *** Pursuant to a Power of Attorney dated as of November 16, 2015

    Page 7 of 7


    Get the next $RCLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RCLF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RCLF
    SEC Filings

    View All

    Rosecliff Acquisition Corp I filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    2/13/24 8:21:46 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    Rosecliff Acquisition Corp I filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    2/12/24 8:18:27 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Rosecliff Acquisition Corp I

    S-8 - Spectral AI, Inc. (0001833498) (Filer)

    2/9/24 8:33:44 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Dimaio John Michael bought $14,651 worth of shares (4,053 units at $3.61) (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    11/22/23 1:11:01 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Spectral MD Holdings, Ltd. ("Spectral MD" or the "Company") ISO 13485 Certification Received for AI-Driven DeepView® Wound Imaging System

    LONDON and DALLAS, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces that it has received ISO 13485 certification for the manufacture and distribution of its AI-driven DeepView® Wound Imaging System which is designed to provide immediate, accurate, and binary wound treatment assessments for Burn and Diabetic Foot Ulcer (DFU) indications. ISO 13485 is an internationally recognized standard that ensures the quality of medical device design, development, and production. To receive certification, organizations must demonstrate

    8/14/23 7:00:31 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Completion of ISO 13485 Certification Audit

    ISO 13485 Certification Recommended and Anticipated in Q3 2023 Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces it has completed the quality management ISO 13485 certification audit for the manufacture and distribution of its DeepView® Wound Imaging System. ISO 13485 certification has now been recommended and is anticipated in Q3 2023. The completion of the audit validates Spectral MD's commitment to meeting the highest standards of quality, reliability, and safety in the medical device industry. ISO 13485 is an internationally recognized quality standar

    6/20/23 7:00:00 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Announces Publication of Peer Reviewed Proof-of-Concept Study Evaluating DeepView® Technology in Journal of Burn Care & Research

    Results Suggest That Combination of Artificial Intelligence and Multispectral Imaging Can Play an Important Role in Predicting Burn Depth Rapidly and Accurately Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on the development of faster and more accurate medical diagnostics for treatment decisions in wound care, announces today that results from its 2018 Proof of Concept Study were published in the peer-reviewed journal, Journal of Burn Care & Research. The study, titled ‘Clinical Investigation of a Rapid Non-invasive Multispectral Imaging Device Utilizing an Artificial Intelligence Algorithm for Improved Burn Assessment', indicates that Spectral MD

    6/13/23 7:00:00 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Dimaio John Michael bought $14,651 worth of shares (4,053 units at $3.61) (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    11/22/23 1:11:01 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    Cotton Richard John was granted 14,650 shares, increasing direct ownership by 45% to 47,529 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    11/20/23 1:53:35 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    New insider Spangenberg Erich claimed ownership of 4,736,131 shares (SEC Form 3)

    3 - Spectral AI, Inc. (0001833498) (Issuer)

    9/26/23 8:47:09 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Leadership Updates

    Live Leadership Updates

    View All

    Gett Appoints Chief Information Security Officer

    Runli Guo has joined as Chief Information Security Officer (CISO) and is based in London. Cyber security remains top priority for Gett as its ground transportation platform attracts ever-larger global accounts from Fortune 500 companies. Gett looks to disrupt the $100 billion a year ground transportation management marketplace. Gett – the ground transportation management (GTM) platform for business travel – has confirmed the appointment of Runli Guo as Chief Information Security Officer (CISO). Runli is based in London and reports to Chief Information Officer (CIO) Dina Dembo-Orgil within the Technology and Innovation Function at Gett. Currently around one quarter of Fortune 500 co

    2/9/22 8:00:00 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Rosecliff Acquisition Corp I

    SC 13G - Spectral AI, Inc. (0001833498) (Subject)

    2/8/24 4:07:26 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Rosecliff Acquisition Corp I

    SC 13G - Spectral AI, Inc. (0001833498) (Subject)

    11/3/23 4:30:18 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by Rosecliff Acquisition Corp I

    SC 13D - Spectral AI, Inc. (0001833498) (Subject)

    9/26/23 8:48:12 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care